Gynecological Drugs Market Size, Share, And Growth Report 2032
Gynecological Drugs Market by Therapeutics (Hormonal Therapy and Non-Hormonal Therapy), by Indication (Gynecology Cancers, Endometriosis, Female Infertility, Menopausal Disorder, Gynecology Infections, Polycystic Ovary Syndrome, Contraception (Birth Control), and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and By Region - Global And Regional Industry Overview, market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2024-2032
| Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 15.61 Billion | USD 29.93 Billion | 7.5% | 2023 |
Table Of Content
- Chapter 1. Introduction
- 1.1. Report description and scope
- 1.2. Research scope
- 1.3. Research methodology
- 1.3.1. Market research process
- 1.3.2. Market research methodology
- Chapter 2. Executive Summary
- 2.1. Global Gynecological Drugs Market, 2016-2025 (USD Million)
- 2.2. Global Gynecological Drugs Market: Snapshot
- Chapter 3. Gynecological Drugs Market - Market Dynamics
- 3.1. Introduction
- 3.2. Market drivers
- 3.2.1. Global Gynecological Drugs market drivers: Impact analysis
- 3.2.2. Rising healthcare expenditure
- 3.2.3. Changing lifestyle of females across the globe
- 3.3. Market Restraints
- 3.3.1. High cost
- 3.3.2. Lack of skilled professionals
- 3.4. Opportunities
- 3.4.1. Technological advancement
- 3.4.2. Increase in Research and development activities
- 3.5. Porter's Five Forces Analysis
- 3.6. Market attractiveness analysis
- 3.6.1. Market attractiveness analysis, by Therapeutics
- 3.6.2. Market attractiveness analysis, by Indication
- 3.6.3. Market attractiveness analysis, by Distribution Channel
- 3.6.4. Market attractiveness analysis, by Region
- Chapter 4. Global Gynecological Drugs Market - Competitive Landscape
- 4.1. Company Market Share Analysis
- 4.1.1. Global Gynecological Drugs Market: company market share, 2016
- 4.2. Strategic Development
- 4.2.1. Acquisitions & Mergers
- 4.2.2. New Launch
- 4.2.3. Agreements, Partnerships, Collaborations, and Joint Ventures
- 4.2.4. R&D
- 4.2.5. Regional Expansion
- 4.3. Price Trend Analysis
- 4.4. Therapeutics Portfolio
- 4.1. Company Market Share Analysis
- Chapter 5. Global Gynecological Drugs Market - Therapeutics Type Analysis
- 5.1. Global Gynecological Drugs Market: Therapeutics overview
- 5.1.1. Global Gynecological Drugs market revenue share, by Therapeutics, 2018 and 2025
- 5.2. Hormonal therapy
- 5.2.1. Global Hormonal therapy Market, 2016-2025 (USD Million)
- 5.3. Non-hormonal therapy
- 5.3.1. Global Non-hormonal therapy Market, 2016-2025 (USD Million)
- 5.1. Global Gynecological Drugs Market: Therapeutics overview
- Chapter 6. Global Gynecological Drugs Market - Indication Analysis
- 6.1. Global Gynecological Drugs: Indication overview
- 6.1.1. Global Gynecological Drugs Market revenue share, by Indication, 2018 and 2025
- 6.2. Gynecology cancers
- 6.2.1. Global Gynecology Cancers Market, 2016-2025 (USD Million)
- 6.3. Endometriosis
- 6.3.1. Global Endometriosis Market, 2016-2025 (USD Million)
- 6.4. Female infertility
- 6.4.1. Global Female infertility Market, 2016-2025 (USD Million)
- 6.5. Menopausal disorder
- 6.5.1. Global Menopausal disorder Market, 2016-2025 (USD Million)
- 6.6. Gynecology infections
- 6.6.1. Global Gynecology infections Market, 2016-2025 (USD Million)
- 6.7. Polycystic ovary syndrome
- 6.7.1. Global Polycystic ovary syndrome Market, 2016-2025 (USD Million)
- 6.8. Contraception (birth control)
- 6.8.1. Global Contraception (birth control) Market, 2016-2025 (USD Million)
- 6.9. Others
- 6.9.1. Global Others Market, 2016-2025 (USD Million)
- 6.1. Global Gynecological Drugs: Indication overview
- Chapter 7. Global Gynecological Drugs Market - Distribution Channel Analysis
- 7.1. Global Gynecological Drugs Market: Distribution Channel overview
- 7.1.1. Global Gynecological Drugs Market revenue share, by Distribution Channel, 2018 and 2025
- 7.2. Hospital Pharmacies
- 7.2.1. Global Hospital Pharmacies Market, 2016-2025 (USD Million)
- 7.3. Retail Pharmacies
- 7.3.1. Global Retail Pharmacies Market, 2016-2025 (USD Million)
- 7.4. Online Pharmacies
- 7.4.1. Global Online Pharmacies Market, 2016-2025 (USD Million)
- 7.1. Global Gynecological Drugs Market: Distribution Channel overview
- Chapter 8. Global Gynecological Drugs Market - Regional Analysis
- 8.1. Global Gynecological Drugs Market: Regional overview
- 8.1.1. Global Gynecological Drugs Market revenue share, by region, 2018 and 2025
- 8.2. North America
- 8.2.1. North America Gynecological Drugs market revenue, by Therapeutics, 2016-2025 (USD Million)
- 8.2.2. North America Gynecological Drugs market revenue, by Indication, 2016-2025 (USD Million)
- 8.2.3. North America Gynecological Drugs market revenue, by Distribution Channel, 2016-2025 (USD Million)
- 8.2.4. The U.S.
- 8.2.4.1. The U.S. Gynecological Drugs market revenue, by Therapeutics, 2016-2025 (USD Million)
- 8.2.4.2. The U.S. Gynecological Drugs market revenue, by Indication, 2016-2025 (USD Million)
- 8.2.4.3. The U.S. Gynecological Drugs market revenue, by Distribution Channel, 2016-2025 (USD Million)
- 8.2.5. Rest of North America
- 8.2.5.1. Rest of North America Gynecological Drugs market revenue, by Therapeutics, 2016-2025 (USD Million)
- 8.2.5.2. Rest of North America Gynecological Drugs market revenue, by Indication, 2016-2025 (USD Million)
- 8.2.5.3. Rest of North America Gynecological Drugs market revenue, by Distribution Channel, 2016-2025 (USD Million)
- 8.3. Europe
- 8.3.1. Europe Gynecological Drugs market revenue, by Therapeutics, 2016-2025 (USD Million)
- 8.3.2. Europe Gynecological Drugs market revenue, by Indication, 2016-2025 (USD Million)
- 8.3.3. Europe Gynecological Drugs market revenue, by Distribution Channel, 2016-2025 (USD Million)
- 8.3.4. Germany
- 8.3.4.1. Germany Gynecological Drugs market revenue, by Therapeutics, 2016-2025 (USD Million)
- 8.3.4.2. Germany Gynecological Drugs market revenue, by Indication, 2016-2025 (USD Million)
- 8.3.4.3. Germany Gynecological Drugs market revenue, by Distribution Channel, 2016-2025 (USD Million)
- 8.3.5. France
- 8.3.5.1. France Gynecological Drugs market revenue, by Therapeutics, 2016-2025 (USD Million)
- 8.3.5.2. France Gynecological Drugs market revenue, by Indication, 2016-2025 (USD Million)
- 8.3.5.3. France Gynecological Drugs market revenue, by Distribution Channel, 2016-2025 (USD Million)
- 8.3.6. UK
- 8.3.6.1. UK Gynecological Drugs market revenue, by Therapeutics, 2016-2025 (USD Million)
- 8.3.6.2. UK Gynecological Drugs market revenue, by Indication, 2016-2025 (USD Million)
- 8.3.6.3. UK Gynecological Drugs market revenue, by Distribution Channel, 2016-2025 (USD Million)
- 8.3.7. Rest of Europe
- 8.3.7.1. Rest of Europe Gynecological Drugs market revenue, by Therapeutics, 2016-2025 (USD Million)
- 8.3.7.2. Rest of Europe Gynecological Drugs market revenue, by Indication, 2016-2025 (USD Million)
- 8.3.7.3. Rest of Europe Gynecological Drugs market revenue, by Distribution Channel, 2016-2025 (USD Million)
- 8.4. Asia Pacific
- 8.4.1. Asia Pacific Gynecological Drugs market revenue, by Therapeutics, 2016-2025 (USD Million)
- 8.4.2. Asia Pacific Gynecological Drugs market revenue, by Indication, 2016-2025 (USD Million)
- 8.4.3. Asia Pacific Gynecological Drugs market revenue, by Distribution Channel, 2016-2025 (USD Million)
- 8.4.4. China
- 8.4.4.1. China Gynecological Drugs market revenue, by Therapeutics, 2016-2025 (USD Million)
- 8.4.4.2. China Gynecological Drugs market revenue, by Indication, 2016-2025 (USD Million)
- 8.4.4.3. China Gynecological Drugs market revenue, by Distribution Channel, 2016-2025 (USD Million)
- 8.4.5. Japan
- 8.4.5.1. Japan Gynecological Drugs market revenue, by Therapeutics, 2016-2025 (USD Million)
- 8.4.5.2. Japan Gynecological Drugs market revenue, by Indication, 2016-2025 (USD Million)
- 8.4.5.3. Japan Gynecological Drugs market revenue, by Distribution Channel, 2016-2025 (USD Million)
- 8.4.6. India
- 8.4.6.1. India Gynecological Drugs market revenue, by Therapeutics, 2016-2025 (USD Million)
- 8.4.6.2. India Gynecological Drugs market revenue, by Indication, 2016-2025 (USD Million)
- 8.4.6.3. India Gynecological Drugs market revenue, by Distribution Channel, 2016-2025 (USD Million)
- 8.4.7. Rest of Asia Pacific
- 8.4.7.1. Rest of Asia Pacific Gynecological Drugs market revenue, by Therapeutics, 2016-2025 (USD Million)
- 8.4.7.2. Rest of Asia Pacific Gynecological Drugs market revenue, by Indication, 2016-2025 (USD Million)
- 8.4.7.3. Rest of Asia Pacific Gynecological Drugs market revenue, by Distribution Channel, 2016-2025 (USD Million)
- 8.5. Latin America
- 8.5.1. Latin America Gynecological Drugs market revenue, by Therapeutics, 2016-2025 (USD Million)
- 8.5.2. Latin America Gynecological Drugs market revenue, by Indication, 2016-2025 (USD Million)
- 8.5.3. Latin America Gynecological Drugs market revenue, by Distribution Channel, 2016-2025 (USD Million)
- 8.5.4. Brazil
- 8.5.4.1. Brazil Gynecological Drugs market revenue, by Therapeutics, 2016-2025 (USD Million)
- 8.5.4.2. Brazil Gynecological Drugs market revenue, by Indication, 2016-2025 (USD Million)
- 8.5.4.3. Brazil Gynecological Drugs market revenue, by Distribution Channel, 2016-2025 (USD Million)
- 8.5.5. Rest of Latin America
- 8.5.5.1. Rest of Latin America Gynecological Drugs market revenue, by Therapeutics, 2016-2025 (USD Million)
- 8.5.5.2. Rest of Latin America Gynecological Drugs market revenue, by Indication, 2016-2025 (USD Million)
- 8.5.5.3. Rest of Latin America Gynecological Drugs market revenue, by Distribution Channel, 2016-2025 (USD Million)
- 8.6. The Middle East and Africa
- 8.6.1. The Middle East and Africa Gynecological Drugs market revenue, by Therapeutics, 2016-2025 (USD Million)
- 8.6.2. The Middle East and Africa Gynecological Drugs market revenue, by Indication, 2016-2025 (USD Million)
- 8.6.3. The Middle East and Africa Gynecological Drugs market revenue, by Distribution Channel, 2016-2025 (USD Million)
- 8.1. Global Gynecological Drugs Market: Regional overview
- Chapter 9. Company Profile
- 9.1. Eli Lilly and Company
- 9.1.1. Overview
- 9.1.2. Financials
- 9.1.3. Therapeutics portfolio
- 9.1.4. Business strategy
- 9.1.5. Recent developments
- 9.2. Pfizer, Inc.
- 9.2.1. Overview
- 9.2.2. Financials
- 9.2.3. Product Type portfolio
- 9.2.4. Business strategy
- 9.2.5. Recent developments
- 9.3. Merck & Co., Inc.
- 9.3.1. Overview
- 9.3.2. Financials
- 9.3.3. Product Type portfolio
- 9.3.4. Business strategy
- 9.3.5. Recent developments
- 9.4. Amgen Inc.
- 9.4.1. Overview
- 9.4.2. Financials
- 9.4.3. Product Type portfolio
- 9.4.4. Business strategy
- 9.4.5. Recent developments
- 9.5. AstraZeneca
- 9.5.1. Overview
- 9.5.2. Financials
- 9.5.3. Product Type portfolio
- 9.5.4. Business strategy
- 9.5.5. Recent developments
- 9.6. F. Hoffmann-La Roche Ltd.
- 9.6.1. Overview
- 9.6.2. Financials
- 9.6.3. Product Type portfolio
- 9.6.4. Business strategy
- 9.6.5. Recent developments
- 9.7. Allergan
- 9.7.1. Overview
- 9.7.2. Financials
- 9.7.3. Product Type portfolio
- 9.7.4. Business strategy
- 9.7.5. Recent developments
- 9.8. Bayer AG
- 9.8.1. Overview
- 9.8.2. Financials
- 9.8.3. Product Type portfolio
- 9.8.4. Business strategy
- 9.8.5. Recent developments
- 9.1. Eli Lilly and Company
Table Of Figures
List of Figures
1. Market research process
2. Market research methodology
3. Global Gynecological Drugs market revenue, 2016–2025 (USD Million)
4. Porter’s Five Forces Analysis
5. Gynecological Drugs market attractiveness analysis, by Therapeutics
6. Gynecological Drugs market: Market attractiveness analysis, by Indication
7. Gynecological Drugs market: Market attractiveness analysis, by Distribution Channel
8. Gynecological Drugs Market: Market attractiveness analysis, by Region
9. Company market share analysis, 2018
10. Global Gynecological Drugs market revenue share by Therapeutics, 2018 and 2025
11. Global Hormonal Therapy market, 2016–2025 (USD Million)
12. Global Non-hormonal Therapy market, 2016–2025 (USD Million)
13. Global Gynecological Drugs market revenue share by Indication, 2018 and 2025
14. Global Gynecology cancers market, 2016–2025 (USD Million)
15. Global Endometriosis market, 2016–2025 (USD Million)
16. Global Female infertility market, 2016–2025 (USD Million)
17. Global Menopausal disorder market, 2016–2025 (USD Million)
18. Global Gynecology infections market, 2016–2025 (USD Million)
19. Global Polycystic ovary syndrome market, 2016–2025 (USD Million)
20. Global Contraception (birth control) market, 2016–2025 (USD Million)
21. Global Others market, 2016–2025 (USD Million)
22. Global Gynecological Drugs market revenue share by Distribution Channel, 2018 and 2025
23. Global Hospital Pharmacies market, 2016–2025 (USD Million)
24. Global Retail Pharmacies market, 2016–2025 (USD Million)
25. Global Online Pharmacies market, 2016–2025 (USD Million)
Table Of Tables
List of Tables
1. Gynecological Drugs: Market Snapshot
2. Drivers of global Gynecological Drugs market: Impact analysis
3. Restraints of global Gynecological Drugs market: Impact analysis
4. North America Gynecological Drugs market revenue, by Therapeutics, 2016–2025 (USD Million)
5. North America Gynecological Drugs market revenue, by Indication, 2016–2025 (USD Million)
6. North America Gynecological Drugs market revenue, by Distribution Channel type, 2016–2025 (USD Million)
7. The U.S. Gynecological Drugs market revenue, by Therapeutics, 2016–2025 (USD Million)
8. The U.S. Gynecological Drugs market revenue, by Indication, 2016–2025 (USD Million)
9. The U.S. Gynecological Drugs market revenue, by Distribution Channel, 2016–2025 (USD Million)
10. Rest of North America Gynecological Drugs market revenue, by Therapeutics, 2016–2025 (USD Million)
11. Rest of North America Gynecological Drugs market revenue, by Indication, 2016–2025 (USD Million)
12. Rest of North America Gynecological Drugs market revenue, by Distribution Channel, 2016–2025 (USD Million)
13. Europe Gynecological Drugs market revenue, by Therapeutics, 2016–2025 (USD Million)
14. Europe Gynecological Drugs market revenue, by Indication, 2016–2025 (USD Million)
15. Europe Gynecological Drugs market revenue, by Distribution Channel, 2016–2025 (USD Million)
16. UK Gynecological Drugs market revenue, by Therapeutics, 2016–2025 (USD Million)
17. UK Gynecological Drugs market revenue, by Indication, 2016–2025 (USD Million)
18. UK Gynecological Drugs market revenue, by Distribution Channel, 2016–2025 (USD Million)
19. Germany Gynecological Drugs market revenue, by Therapeutics, 2016–2025 (USD Million)
20. Germany Gynecological Drugs market revenue, by Indication, 2016–2025 (USD Million)
21. Germany Gynecological Drugs market revenue, by Distribution Channel, 2016–2025 (USD Million)
22. France Gynecological Drugs market revenue, by Therapeutics, 2016–2025 (USD Million)
23. France Gynecological Drugs market revenue, by Indication, 2016–2025 (USD Million)
24. France Gynecological Drugs market revenue, by Distribution Channel, 2016–2025 (USD Million)
25. Rest of Europe Gynecological Drugs market revenue, by Therapeutics, 2016–2025 (USD Million)
26. Rest of Europe Gynecological Drugs market revenue, by Indication, 2016–2025 (USD Million)
27. Rest of Europe Gynecological Drugs market revenue, by Distribution Channel, 2016–2025 (USD Million)
28. Asia Pacific Gynecological Drugs market revenue, by Therapeutics, 2016–2025 (USD Million)
29. Asia Pacific Gynecological Drugs market revenue, by Indication, 2016–2025 (USD Million)
30. Asia Pacific Gynecological Drugs market revenue, by Distribution Channel, 2016–2025 (USD Million)
31. China Gynecological Drugs market revenue, by Therapeutics, 2016–2025 (USD Million)
32. China Gynecological Drugs market revenue, by Indication, 2016–2025 (USD Million)
33. China Gynecological Drugs market revenue, by Distribution Channel, 2016–2025 (USD Million)
34. Japan Gynecological Drugs market revenue, by Therapeutics, 2016–2025 (USD Million)
35. Japan Gynecological Drugs market revenue, by Indication, 2016–2025 (USD Million)
36. Japan Gynecological Drugs market revenue, by Distribution Channel, 2016–2025 (USD Million)
37. India Gynecological Drugs market revenue, by Therapeutics, 2016–2025 (USD Million)
38. India Gynecological Drugs market revenue, by Indication, 2016–2025 (USD Million)
39. India Gynecological Drugs market revenue, by Distribution Channel, 2016–2025 (USD Million)
40. Rest of Asia Pacific Gynecological Drugs market revenue, by Therapeutics, 2016–2025 (USD Million)
41. Rest of Asia Pacific Gynecological Drugs market revenue, by Indication, 2016–2025 (USD Million)
42. Rest of Asia Pacific Gynecological Drugs market revenue, by Distribution Channel, 2016–2025 (USD Million)
43. Latin America Gynecological Drugs market revenue, by Therapeutics, 2016–2025 (USD Million)
44. Latin America Gynecological Drugs market revenue, by Indication, 2016–2025 (USD Million)
45. Latin America Gynecological Drugs market revenue, by Distribution Channel, 2016–2025 (USD Million)
46. Brazil Gynecological Drugs market revenue, by Therapeutics, 2016–2025 (USD Million)
47. Brazil Gynecological Drugs market revenue, by Indication, 2016–2025 (USD Million)
48. Brazil Gynecological Drugs market revenue, by Distribution Channel, 2016–2025 (USD Million)
49. Rest of Latin America Gynecological Drugs market revenue, by Therapeutics, 2016–2025 (USD Million)
50. Rest of Latin America Gynecological Drugs market revenue, by Indication, 2016–2025 (USD Million)
51. Rest of Latin America Gynecological Drugs market revenue, by Distribution Channel, 2016–2025 (USD Million)
52. The Middle East and Africa Gynecological Drugs market revenue, by Therapeutics, 2016–2025 (USD Million)
53. The Middle East and Africa Gynecological Drugs market revenue, by Indication, 2016–2025 (USD Million)
54. The Middle East and Africa Gynecological Drugs market revenue, by Distribution Channel, 2016–2025 (USD Million)
Methodology
FrequentlyAsked Questions
Gynecological drugs are medications used to treat various conditions related to women's reproductive health. These drugs can address issues ranging from hormonal imbalances and menstrual disorders to fertility challenges and menopause symptoms.
According to study, the Gynecological Drugs Market size was worth around USD 15.61 billion in 2023 and is predicted to grow to around USD 29.93 billion by 2032.
The CAGR value of Gynecological Drugs Market is expected to be around 7.5% during 2024-2032.
North America has been leading the Gynecological Drugs Market and is anticipated to continue on the dominant position in the years to come.
The Gynecological Drugs Market is led by players like Merck & Co., Inc., F. Hoffmann-La Roche Ltd., Eli Lilly and Company, Pfizer, Inc., Amgen Inc., AstraZeneca, Allergan, and Bayer AG, among others.
HappyClients
